Humacyte Inc

HUMA

Company Profile

  • Business description

    Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

  • Contact

    2525 East North Carolina Highway 54
    DurhamNC27713
    USA

    T: +1 919 313-9633

    https://www.humacyte.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    220

Stocks News & Analysis

stocks

Going into earnings, is Tesla stock a buy, a sell, or fairly valued?

Awaiting more info on robotaxis and lower cost models, here’s what we think of Tesla stock.
stocks

Why I dislike dividend stocks

If you need income then buying dividend stocks makes perfect sense. But if you don’t then it makes little sense because it’s likely to limit building real wealth. Here’s what you should do instead.
stocks

Chart of the Week: Ramsay Health Care margins to rebound

Charts from our latest stock pitch for Ramsay Health Care show a clear path to improved profitability.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,293.2045.10-0.48%
CAC 408,195.697.100.09%
DAX 4023,896.77375.42-1.55%
Dow JONES (US)45,952.24301.07-0.65%
FTSE 1009,349.4086.69-0.92%
HKSE25,247.10641.41-2.48%
NASDAQ22,562.54107.54-0.47%
Nikkei 22547,582.15695.59-1.44%
NZX 50 Index13,289.2199.89-0.75%
S&P 5006,629.070.000.00%
S&P/ASX 2008,995.3034.70-0.38%
SSE Composite Index3,839.7676.47-1.95%

Market Movers